Preclinical Research After the identification of the schizophrenia as an illness over a century ago, treatment of affected individuals included unspecific, mostly very robust methods including deep insulin coma and lobectomy/leucotomy. The first relatively specific treatment of schizophrenia started about ...
Dysbiosis and Metabolic Dysregulation of Salivary Microbiota in Schizophrenia Jie Wang, Lin Lu, Le Ren, Rui Zhu, Yao Jiang, Yanan Qiao & Yongming Li Pages: 813-825 Published online: 12 Feb 2025 AbstractforDysbiosis and Metabolic Dysregulation of Salivary Microbiota in Schizophrenia | Full Text |...
Current Treatment Options in Psychiatryfocuses on the latest advances in the multifaceted treatment of psychiatric disorders. The journal offers expert reviews on the management of a range of mental health conditions, including schizophrenia and other psychotic disorders; substance use disorders; anxiety, ...
The authors present the summary of current trends in the pharmacological treatment of schizophrenia pre-sented during the XIV World Congress of Psychiatry (Prague, Czech Republic, 19-25 September 2008). The results of studies presented during the Congress, recommendations and new trends may be divid...
The advent of the “atypical” antipsychotics has significantly advanced the pharmacologic treatment of schizophrenia and other psychotic disorders. In contrast to the first-generation conventional neuroleptics, these second-generation antipsychotic agents possess a broader spectrum of efficacy and cause fewer...
Since November 2022, generative artificial intelligence (AI) chatbots, such as ChatGPT, that are powered by large language models (LLM) have been the subje
Here, we provide an overview of the promising therapeutic avenues for Batten disease, highlighting current FDA-approved clinical trials and prospective future treatments. Key points The FDA approval of the enzyme replacement therapy cerliponase alfa (Brineura) for the treatment of CLN2 Batten disease...
Current inpatient prescription practices for the treatment of schizophrenia in public hospitals of Minas Gerais , Brazil Current inpatient prescription practices for the treatment of schizophrenia in public hospitals of Minas Gerais , Brazilsex occasions is 100%, which would ... AN Pala,K Mckinnon,M...
Purpose of Review Schizophrenia is a leading cause of disease burden in youth and can significantly impair an adolescent’s peer and familial relationships and academic functioning. Therefore, safe and effective treatments are needed. This article reviews the pharmacological treatment of adolescents with ...
Guthrie SK: Clinical issues associated with maintenance treatment of patients with schizophrenia. Am J Health Syst Pharm 2002, 59(Suppl 5): S19-S24. PubMed Google Scholar Bonelli RM, Mahnert FA, Niederwieser G: Olanzapine for Huntington’s disease: an open label study. Clin Neuropharmacol 20...